The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 11, 2010
Filed:
Aug. 28, 2006
Adnan M. M. Mjalli, Oak Ridge, NC (US);
Robert C. Andrews, Jamestown, NC (US);
Ramesh Gopalaswamy, Jamestown, NC (US);
Anitha Hari, High Point, NC (US);
Kwasi A. Avor, High Point, NC (US);
Ghassan Qabaja, Jamestown, NC (US);
Xiao-chuan Guo, High Point, NC (US);
Suparna Gupta, Greensboro, NC (US);
David R. Jones, Asheboro, NC (US);
Xin Chen, High Point, NC (US);
Adnan M. M. Mjalli, Oak Ridge, NC (US);
Robert C. Andrews, Jamestown, NC (US);
Ramesh Gopalaswamy, Jamestown, NC (US);
Anitha Hari, High Point, NC (US);
Kwasi A. Avor, High Point, NC (US);
Ghassan Qabaja, Jamestown, NC (US);
Xiao-Chuan Guo, High Point, NC (US);
Suparna Gupta, Greensboro, NC (US);
David R. Jones, Asheboro, NC (US);
Xin Chen, High Point, NC (US);
Transtech Pharma, Inc., High Point, NC (US);
Abstract
This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, β-amyloid and amphoterin, and for the management, treatment, control, or as an adjunct treatment for diseases in humans caused by RAGE. Such diseases or disease states include acute and chronic inflammation, the development of diabetic late complications such as increased vascular permeability, nephropathy, atherosclerosis, and retinopathy, the development of Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis.